Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CFD | P00746 | 15/20 | 0.44 |
| ▸ | ELANE | P08246 | 1/20 | 0.37 |
| ▸ | HTR3A | P46098 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.35 |
| ▸ | PARP1 | P09874 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29781499 | 0.87 | CFD (0.44) | CFDELANEPLA2G2APARP1 | |
| SCHEMBL17026682 | 0.87 | CFD (0.44) | CFDELANEPLA2G2APARP1 | |
| SCHEMBL25926051 | 0.86 | CFD (0.44) | CFDELANEPLA2G2APARP1 | |
| SCHEMBL25926028 | 0.85 | CFD (0.44) | CFDELANE | |
| SCHEMBL25926026 | 0.85 | CFD (0.40) | CFDELANE | |
| SCHEMBL17026611 | 0.82 | CFD (0.40) | CFDELANE | |
| SCHEMBL25926045 | 0.82 | MAP3K14 (0.42) | CFD | |
| SCHEMBL25925645 | 0.81 | ELANE (0.45) | ELANEPLA2G2A | |
| SCHEMBL19236981 | 0.81 | CFD (0.40) | CFDELANEHTR3AGAAPLA2G2A | |
| SCHEMBL18549496 | 0.79 | CFD (0.47) | CFDELANEHTR3AGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230218578-A1 | BENZOPYRAZOLE COMPOUNDS AND ANALOGUES THEREOF | WILMINGTON TRUST, NATIONAL ASSOCIATION | 2023-07-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230218578-A1 | BENZOPYRAZOLE COMPOUNDS AND ANALOGUES THEREOF | C9, C5, C1QBP | CFD 13/4885ELANE 119/4885HTR3A 928/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.